DHR(DHR)
DHR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $26.26B | $28.38B | $30.22B | $32.49B | $33.86B |
| Low | $25.62B | $27.18B | $29.53B | $31.78B | $33.12B |
| High | $26.46B | $28.92B | $31.01B | $33.00B | $34.39B |
| EBITDA Avg | $8.39B | $9.06B | $9.65B | $10.38B | $10.81B |
| Low | $8.18B | $8.68B | $9.43B | $10.15B | $10.58B |
| High | $8.45B | $9.24B | $9.91B | $10.54B | $10.99B |
| EBIT Avg | $6.07B | $6.55B | $6.98B | $7.50B | $7.82B |
| Low | $5.92B | $6.28B | $6.82B | $7.34B | $7.65B |
| High | $6.11B | $6.68B | $7.16B | $7.62B | $7.94B |
| Net Income Avg | $6.03B | $6.58B | $7.22B | $8.10B | $8.87B |
| Low | $6.00B | $6.49B | $6.51B | $7.87B | $8.62B |
| High | $6.05B | $6.65B | $7.59B | $8.26B | $9.06B |
| EPS Avg | $8.50 | $9.26 | $10.18 | $11.39 | $12.48 |
| Low | $8.44 | $9.13 | $9.15 | $11.07 | $12.13 |
| High | $8.52 | $9.36 | $10.68 | $11.62 | $12.74 |
| Analysts (Rev / EPS) | 17 / 14 | 17 / 14 | 14 / 5 | 8 / 1 | 12 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $6.53B | $7.53B | $6.63B | $6.84B | $6.87B | $7.91B | $6.90B | $7.09B |
| Low | $6.32B | $7.12B | $6.46B | $6.66B | $6.69B | $7.70B | $6.72B | $6.90B |
| High | $6.59B | $7.70B | $6.74B | $6.95B | $6.98B | $8.03B | $7.01B | $7.20B |
| EBITDA Avg | $2.09B | $2.41B | $2.12B | $2.18B | $2.19B | $2.53B | $2.20B | $2.26B |
| Low | $2.02B | $2.27B | $2.06B | $2.13B | $2.14B | $2.46B | $2.15B | $2.20B |
| High | $2.10B | $2.46B | $2.15B | $2.22B | $2.23B | $2.57B | $2.24B | $2.30B |
| EBIT Avg | $1.51B | $1.74B | $1.53B | $1.58B | $1.59B | $1.83B | $1.59B | $1.64B |
| Low | $1.46B | $1.64B | $1.49B | $1.54B | $1.54B | $1.78B | $1.55B | $1.59B |
| High | $1.52B | $1.78B | $1.56B | $1.60B | $1.61B | $1.86B | $1.62B | $1.66B |
| Net Income Avg | $1.37B | $1.82B | $1.58B | $1.49B | $1.51B | $1.95B | $1.70B | $1.57B |
| Low | $1.33B | $1.76B | $1.53B | $1.44B | $1.45B | $1.88B | $1.65B | $1.52B |
| High | $1.46B | $1.86B | $1.61B | $1.52B | $1.54B | $1.99B | $1.74B | $1.61B |
| EPS Avg | $1.93 | $2.57 | $2.24 | $2.11 | $2.13 | $2.75 | $2.41 | $2.22 |
| Low | $1.88 | $2.48 | $2.16 | $2.03 | $2.05 | $2.66 | $2.33 | $2.15 |
| High | $2.07 | $2.63 | $2.28 | $2.15 | $2.17 | $2.81 | $2.46 | $2.27 |
| Analysts (Rev / EPS) | 13 / 14 | 12 / 14 | 9 / 6 | 9 / 10 | 9 / 6 | 9 / 8 | 5 / 9 | 5 / 7 |